Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Weifeng Mi
Peking University
No. 38 Xueyuan Road
Haidian District
Beijing, Beijing 100871
China
Contact
Peking University
Email
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
45
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Efficacy, Safety, and Tolerability of Ansofaxine (Ly03005) Extended-Release Tablet for Major Depressive Disorder: A Randomized, Double-Blind, Placebo Controlled, Dose-Finding, Phase 2 Clinical Trial
Number of pages: 29
Posted: 27 Jul 2021
Weifeng Mi,
Fude Yang
,
Huafang Li
,
Xiufeng Xu
,
Lehua Li
,
Qingrong Tan
,
Guoqiang Wang
,
Kerang Zhang
,
Feng Tian
,
Jiong Luo
,
Jielai Xia
,
Kai Yuan
,
Lin Lu
,
Jiahui Deng
,
Jingwei Tian
and
Hongyan Zhang
Peking University, Peking University - Beijing HuiLongGuan Hospital, Shanghai Jiao Tong University (SJTU) - Shanghai Mental Health Center, Department of Psychiatry, The First Affiliated Hospital of Kunming Medical University, Central South University - Second Xiangya Hospital, Government of the People's Republic of China - Department of Psychiatry, Nanjing Medical University - Wuxi Mental Health Center, Shanxi Medical University, Shanxi Medical University, Capital Medical University, Government of the People's Republic of China - Air Force Medical University, Peking University, Peking University - School of Public Health, Peking University, Yantai University - Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong and Peking University - NHC Key Laboratory of Mental Health
Downloads
45
(1,121,190)
View PDF
Download
Abstract:
Feedback